All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
During the Society of Hematologic Oncology (SOHO) 2022 Annual Meeting, the Lymphoma Hub spoke with Professor Catherine Thieblemont from the Hôpital Saint-Louis, Paris, France. We asked, How can we improve care for elderly patients with aggressive lymphomas?
How can we improve care for elderly patients with aggressive lymphomas?
Thieblemont explains our improved ability to predict treatment responses according to baseline risk and discusses how recent phase II trials have contributed to advances in this fast moving field.
Understanding your specialty helps us to deliver the most relevant and engaging content.
Please spare a moment to share yours.
Please select or type your specialty
Prof. John Gribben | ASH 2017 | Major advances in immunotherapies during ASH 2017
59th ASH Annual Meeting and Exposition Professor John Gribben Barts Cancer Institute, London, UK Major advances in immunotherapies during ASH 2017 in lymphoma and...
Prof. Pierre Soubeyran | 2017 ASCO Annual Meeting | New approaches for older adults - Individualized management of aggressive lymphoma
Professor Pierre Soubeyran discusses new approaches for older patients and indivualized management for aggressive...
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox